A Study to Measure Stomach Emptying in Overweight Non-diabetic and Diabetic Participants Using Tirzepatide

I8F-MC-GPHU -

The purpose of this study is to learn more about how tirzepatide affects stomach emptying in overweight/very overweight participants. Participants include those without diabetes and those with type 2 diabetes.

Trial Summary

Age Range
18 - 65 years
Conditions the trial is for
Type 2 Diabetes, Obesity
What the trial is testing?
Acetaminophen, Tirzepatide
Could I receive a Placebo?
No
Enrollment Goal
36
Trial Dates
Sep 15, 2020 - Jan 7, 2021
How long will I be in the trial?
Participation will last about 13 weeks, including screening.
Trial Phase
I

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.